I think the PPS movement up/down is expected 'till
I think the PPS movement up/down is expected 'till something concrete is released by the company on HC.
It's easy to forget that this after all is the OTC and unless you play the game everyday it's hard to figure out what's happening. It's kinda like getting invited to come out and play hockey with a group of guys who've been playing together for 10 years and they didn't tell you half of them used to play in the pros.
I suspect that most of the longs here are not OTC players; could be wrong but that's my guess.
Creative Edge Nutrition Inc. (FITX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...
Continue Reading
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...
Continue Reading
NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...
Continue Reading
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...
Continue Reading
Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...
Continue Reading
Top 5 Most Recently Viewed Articles
Healthcare Asset Management Market Overview The Healthcare Asset Management market has been experiencing remarkable growth, with projections estimating its value to exceed USD 166.82 billion. This rapid expansion is driven by an impressive compound annual growth rate (CAGR) of 23.1% from 2024 to 2032. This article delves into the reasons behind this growth and what the...
Continue Reading
Chijet Motor Company Announces Strategic Partnership Chijet Motor Company, Inc. (NASDAQ: CJET), proudly unveils its agreement with EdgeAI Frontier Technology Ltd. This partnership aims to secure up to $1 billion in EdgeAI tokens at a remarkable 20% discount off current market prices. This strategic collaboration transcends traditional operations, marking a significant...
Continue Reading
Myriad Genetics Faces Market Challenges Myriad Genetics, Inc. (NASDAQ: MYGN) has recently hit a new 52-week low, marking a critical moment for the company with stock prices plummeting to $12.16. This decline highlights a tough market landscape for the firm, which specializes in genetic testing and precision medicine. Over the last six months, the stock has seen a...
Continue Reading
Veriff Expands into Latin America Veriff, a pioneering company in AI-driven identity verification, is excited to announce its recent expansion into Latin America with the opening of a new headquarters in Brazil. This strategic initiative comes as part of Veriff's growth strategy, following exceptional increases in business volumes in the region, noted at more than two and...
Continue Reading
Overview of Lam Research Earnings Anticipation Lam Research Corporation (NASDAQ:LRCX) is on the cusp of announcing its earnings for the first quarter. This significant moment is eagerly awaited by investors and analysts alike, particularly following a year of notable growth. Current estimates suggest that Lam Research is set to report earnings of $1.22 per share, a jump...
Continue Reading